CDC gathers to discuss which patient groups should get Moderna and J&J COVID-19 vaccine boosters, and Pfizer reports positive results in booster trial
October 21, 2021 at 10:35 AM EDT
There was a flurry of positive news on vaccine boosters Thursday, as the Centers for Disease Control and Prevention gathered to discuss which patient groups should be eligible for the boosters developed by Moderna and Johnson & Johnson.
